Founded in 2003, Cambridge antibody technology is one of the most advanced biotechnologies in the world. This is a lab-on-a-chip based platform that uses the power of molecular biology to determine the specificity and sensitivity of antibodies. The platform uses just four minutes from an antibody preparation to finding antibodies that are specific for cancerous tissues. The platform is designed to be used as a stepping stone for developing more sensitive and efficient cancer antibodies for use in vaccine development.